10,860 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 10,860 companies in the field of Biotechnology on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Patients, Drug, Research, Disease, Treatment, Medical, Dr .

Start-ups (1,582)

Early-stage companies (2,436)

Established companies (5,588)

The majority of these companies is located in the following countries.

United States (5,720)

United Kingdom (642)

Canada (402)

Germany (373)

Example Companies

Find companies in your area

Madison Vaccines Madison Vaccines Inc

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

agents. Pilot Trial of pTVG-HP (MVI-816) DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer pTVG-HP [MVI-816] ...

Vaccine With or Without pTVG-AR [MVI-118] DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer Phase II Trial of ...

Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) and Nivolumab in Patients With Non-Metastatic, PSA-Recurrent Prostate Cancer Safety and tolerability ...

non-metastatic prostate cancer, and prolonged duration of disease control in patients already receiving ADT and/or second generation AR inhibitors in the case ...

benefit, and significantly improving quality of life for prostate cancer patients. Click to enlarge Innovative Therapies for Prostate Cancer Address

CompaniesPartner with MVI Resources Publications About UsContact Us For Patients MVI's immunotherapies: changing PSA progression, impacting bone metastases ...

disease progression MVI is committed to making immunotherapy work for patients with prostate cancer, using combinations of our plasmid DNA along with ...

time - Working to help define those mechanisms of immune resistance in patients so alternative strategies can be developed to overcome this resistance ...

this is all good news for PrCa patients. But you deserve better. There are powerful new therapies available to treat patients with advanced cancers. They ...

every day, with you in mind. You are our focus. MVI is focused on our patients; men with prostate cancer. We know the burden it puts on you and your families

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

- Skip to main content - EURORDIS TV / The Voice of Rare Disease Patients in Europe Donate - About EURORDIS - Who we are - What we do - International ...

of rare diseases on the lives of patients and family. Advocating for Patients EURORDIS represents 30 million patients affected by over 5000 distinct rare ...

institutions for policies that address the needs of patients and their families. Advocating for Patients read more... Healthcare and social policies and ...

disease patients’ representatives Patient Empowerment and Training read more... Information & Networking EURORDIS encourages rare disease patients and ...

voice of rare disease patients in Europe The international voice of people living with rare diseases Bringing together patients, families and experts to ...

EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers

- Skip to main content - EURORDIS TV / The Voice of Rare Disease Patients in Europe Donate - About EURORDIS - Who we are - What we do - International ...

working party: - Committee for Orphan Medicinal Products (COMP) since 2000 - Patients' and Consumers' Working Party (PCWP) since 2006 - Paediatric Committee ...

(PDCO) since 2008 - Committee for Advanced Therapies (CAT) since 2009 Three patients' representatives sit on the Committee for Orphan Medicinal Products (COMP) ...

Vice-Chair of the COMP has to date always been held by a patients' representative. Patients' representatives in EMA scientific committees are permanent ...

permanent and full members with equal voting rights. Rare disease patients are also solicited as experts on the development of products related to their disease ...

include: - Promoting drug development - Ensuring clear information to patients - Attempting to achieve equal access to treatments both at European and

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

treatment for cancer patients. About us Personalized Medicine Improving the selection of drug treatment for individual cancer patients is of high importance ...

is based on testing drug sensitivity on ex vivo 3D tumor cultures from patients. Our Drug Response Platform is proven effective for identification and ...

large number of patients’ samples. About VitroScan develops diagnostic tests to improve selection of drug treatment for cancer patients. Read more Technology ...

accurate drug response analysis on 3D tumor cultures derived from cancer patients. Read more Pipeline Collaborate in trials with leading Dutch Oncology

development of diagnostic tests to improve selection of drug treatment for cancer patients. Technology Functional testing: Ex vivo testing of tumor tissue (avatar ...

Medicine for cancer patients. VitroScans' best-in-class technology is based on testing drug sensitivity on 3D tumor cultures from patients. The Drug Response ...

cancer pathways. Data acquired in trials for multiple solid tumors from patients are the basis for correlate drug sensitivity, and genetic analysis with

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Institutes of Health Sedentary Patients Blair Sedentary Patients Lee Active Patients Guo Active Patients Kyle Athletic Patients American Dietetic Association ...

Athletic Patients Chapman Athletic Patients Fornetti Elderly Patients Berger Elderly Patients Hughes Elderly Patients Omran Elderly Patients Roubenoff

Institutes of Health Sedentary Patients Blair Sedentary Patients Lee Active Patients Guo Active Patients Kyle Athletic Patients American Dietetic Association ...

Athletic Patients Chapman Athletic Patients Fornetti Elderly Patients Berger Elderly Patients Hughes Elderly Patients Omran Elderly Patients Roubenoff

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

trials, and getting enrolled in them. We offer a full concierge service to patients: Our team of Trial Companions leverage our trial matching technology, ...

understand that fighting cancer is complicated enough. We believe in guiding patients through navigating the complexities of clinical trial searching, selection ...

selection, and enrollment. CTC offers full concierge services to help cancer patients find, select and enroll in clinical trials. Selection of participants ...

matches. Our Trial Companions find the best matching clinical trials, help patients understand the matching trials, and complete the enrollment process for ...

navigating the trial process. At CTC we are committed to supporting cancer patients through the duration of the clinical trial. Our Trial Companions, as well ...

collection of technology enabled tools, provide a support platform for patients completing clinical trials. Meet Our Team CHRISTOPHER MALTER Chairman

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

All companies in this field address the following more general topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.